Krsnaa Diagnostics Limited (NSE:KRSNAA)
India · Delayed Price · Currency is INR 539.80
+5.50 (1.03%)
Jun 15, 2026, 3:30 PM IST
Krsnaa Diagnostics Market Cap
Krsnaa Diagnostics has a market cap or net worth of 17.33 billion as of June 15, 2026. Its market cap has decreased by -16.57% in one year.
Market Cap
17.33B
Enterprise Value
19.07B
Revenue
7.99B
Ranking
n/a
PE Ratio
17.30
Stock Price
539.80
Market Cap Chart
Since August 16, 2021, Krsnaa Diagnostics's market cap has decreased from 30.99B to 17.33B, a decrease of -44.07%. That is a compound annual growth rate of -11.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 17.33B | -25.93% |
| Dec 31, 2025 | 23.40B | -18.16% |
| Dec 31, 2024 | 28.59B | 25.42% |
| Dec 29, 2023 | 22.80B | 57.53% |
| Dec 30, 2022 | 14.47B | -37.50% |
| Dec 31, 2021 | 23.15B | -25.28% |
| Aug 16, 2021 | 30.99B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.34T |
| Divi's Laboratories | 1.76T |
| Apollo Hospitals Enterprise | 1.22T |
| Cipla | 1.12T |
| Sakar Healthcare | 18.34B |
| Shalby | 18.16B |
| Beta Drugs | 17.88B |
| Windlas Biotech | 17.40B |